• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS AM filed by GoHealth Inc.

    7/21/26 5:22:17 PM ET
    $GOCO
    Specialty Insurers
    Finance
    Get the next $GOCO alert in real time by email
    POS AM 1 goco-20260721xformsx3x333x.htm POS AM Document

    As filed with the Securities and Exchange Commission on July 21, 2026
    Registration No. 333-291587
    Registration No. 333-292177
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549
    POST-EFFECTIVE AMENDMENT NO. 1 TO
    FORM S-3 REGISTRATION STATEMENT NO. 333-291587
    POST-EFFECTIVE AMENDMENT NO. 1 TO
    FORM S-3 REGISTRATION STATEMENT NO. 333-292177
    UNDER
    THE SECURITIES ACT OF 1933
    GoHealth, Inc.
    (New GoHealth, LLC, as successor by conversion to GoHealth, Inc.)
    (Exact name of registrant as specified in its charter)
    Delaware
    85-0563805
    (State or other jurisdiction of incorporation or organization)
    (I.R.S. Employer Identification No.)
    222 W Merchandise Mart Plaza, Suite 1750
    Chicago, IL 60654
    (312) 386-8200
    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
    Bradley Burd
    Chief Legal Officer
    222 W Merchandise Mart Plaza, Suite 1750
    Chicago, IL 60654
    (312) 386-8200
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
    Copy to:
    Sharon Freiman, P.C.
    Kirkland & Ellis LLP
    601 Lexington Avenue
    New York, NY 10022
    (212) 446-4800



    Approximate date of commencement of proposed sale to the public: Not applicable.
    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☐
    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer
    ☐
    Accelerated filer
    ☐
    Non-accelerated filer
    ☒
    Smaller reporting company
    ☒
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐



    DEREGISTRATION OF SECURITIES
    These post-effective amendments (the “Post-Effective Amendments”) are being filed by New GoHealth, LLC, a Delaware limited liability company (as successor by conversion to GoHealth, Inc.) (the “Company”), to deregister any and all securities registered but unsold or otherwise unissued as of the date hereof, and to terminate all offerings, under the following Registration Statements on Form S-3 (the “Registration Statements”) filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”), each as amended or supplemented to date:
    •Registration Statement on Form S-3 (No. 333-291587), originally filed with the SEC on November 17, 2025, registering up to 12,026,489 shares of Class A common stock, par value $0.0001 per share, of the Company (“Class A Common Stock”).
    •Registration Statement on Form S-3 (No. 333-292177), originally filed with the SEC on December 16, 2025, registering up to 9,566,028 shares of Class A Common Stock.
    As previously disclosed, on June 7, 2026, the Company, GoHealth Holdings, LLC and certain of their direct and indirect subsidiaries (the “Debtors”) filed voluntary petitions commencing cases under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). On July 13, 2026, the Debtors filed the Amended Joint Prepackaged Chapter 11 Plan of GoHealth, Inc. and Its Debtor Affiliates (the “Plan”). On July 21, 2026, the Bankruptcy Court entered the Findings of Fact, Conclusions of Law, and Order (I) Approving the Disclosure Statement for, and Confirming the Amended Joint Prepackaged Chapter 11 Plan of GoHealth, Inc. and Its Debtor Affiliates and (II) Granting Related Relief. The Plan became effective on July 21, 2026. In connection with the foregoing, the offerings pursuant to the Registration Statements are being terminated.
    In accordance with an undertaking made by the Company in each of the Registration Statements to remove from registration, by means of post-effective amendments, any of the securities that remain unsold at the termination of the offering, the Company hereby removes from registration all securities that were registered but unsold or otherwise unissued under each of the Registration Statements as of the date hereof. As of the date hereof, the Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such securities, and the Company hereby terminates the effectiveness of the Registration Statements.



    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused these Post-Effective Amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Chicago, State of Illinois, on the 21st day of July, 2026.
    New GoHealth, LLC, as successor by conversion to GoHealth, Inc.
    By:    /s/ Vijay Kotte    
        Vijay Kotte
        Chief Executive Officer
    No other person is required to sign these Post-Effective Amendments in reliance upon Rule 478 under the Securities Act of 1933, as amended.


    Get the next $GOCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GOCO

    DatePrice TargetRatingAnalyst
    11/19/2025Outperform → Mkt Perform
    William Blair
    4/1/2022$1.50Underperform
    Credit Suisse
    3/3/2022$10.00 → $2.00Outperform → Sector Perform
    RBC Capital
    3/2/2022Buy → Hold
    Truist
    3/2/2022$2.00Buy → Hold
    Truist Securities
    1/7/2022$6.00 → $3.00Neutral → Underperform
    Credit Suisse
    1/5/2022$7.50 → $3.50Buy → Underperform
    B of A Securities
    11/15/2021$7.00 → $6.00Neutral
    Credit Suisse
    More analyst ratings

    $GOCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GoHealth downgraded by William Blair

    William Blair downgraded GoHealth from Outperform to Mkt Perform

    11/19/25 8:54:30 AM ET
    $GOCO
    Specialty Insurers
    Finance

    Credit Suisse resumed coverage on GoHealth with a new price target

    Credit Suisse resumed coverage of GoHealth with a rating of Underperform and set a new price target of $1.50

    4/1/22 7:10:27 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth downgraded by RBC Capital with a new price target

    RBC Capital downgraded GoHealth from Outperform to Sector Perform and set a new price target of $2.00 from $10.00 previously

    3/3/22 4:36:13 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    SEC Filings

    View All

    SEC Form 15-12G filed by GoHealth Inc.

    15-12G - GoHealth, Inc. (0001808220) (Filer)

    7/21/26 5:26:30 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - GoHealth, Inc. (0001808220) (Filer)

    7/21/26 5:23:17 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form POS AM filed by GoHealth Inc.

    POS AM - GoHealth, Inc. (0001808220) (Filer)

    7/21/26 5:22:17 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GoHealth Successfully Completes Financial Restructuring and Emerges Well Positioned for Future Success

    CHICAGO, July 21, 2026 (GLOBE NEWSWIRE) -- GoHealth ("GoHealth" or the "Company") today announced that it successfully completed its financial restructuring and emerged from Chapter 11 pursuant to its prepackaged plan of reorganization, confirmed by the U.S. Bankruptcy Court for the District of Delaware on July 21, 2026. GoHealth emerges from its financial restructuring poised to maintain its position as a leading health insurance marketplace and Medicare-focused digital health company. With the support of new ownership, GoHealth is well positioned for future success and will continue serving its Medicare consumers and partners. Chief Executive Officer Vijay Kotte said, "We are pleased t

    7/21/26 4:12:37 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders

    Initiates voluntary prepackaged Chapter 11 process to implement Restructuring Transactions that have the support of 100% of its lenders, over 60% of the holders of GoHealth, Inc. Class A Common Stock, and over 99% of the holders of GoHealth Holdings, LLC interests. Plans to continue operations without interruption and it is business-as-usual for the Company in providing service for existing Medicare consumers and partners. CHICAGO, June 07, 2026 (GLOBE NEWSWIRE) -- GoHealth, Inc. ("GoHealth" or the "Company"), a health insurance marketplace and Medicare-focused digital health company, announced that GoHealth and certain of its subsidiaries have voluntarily filed chapter 11 petitions (the

    6/7/26 3:40:12 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results

    Disciplined posture reflects consumer-first enrollment, an intentional Medicare Advantage pullback driven by market realities, continued special needs plans ("SNP") leadership, targeted AI investment, and a focus on cash, back-book durability, and consolidation readiness CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and twelve months ended December 31, 2025. GoHealth's Chief Executive Officer, Vijay Kotte commented, "The Medicare Advantage market remains in a structural reset going into 2026, and our

    3/31/26 4:20:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Shanahan Brendan Richard covered exercise/tax liability with 12,725 shares, decreasing direct ownership by 5% to 237,275 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    11/4/25 3:15:09 PM ET
    $GOCO
    Specialty Insurers
    Finance

    Chief Operating Officer Hargis Mike covered exercise/tax liability with 5,545 shares, decreasing direct ownership by 2% to 324,993 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    9/16/25 4:46:40 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Weinsten Mark Robert

    3 - GoHealth, Inc. (0001808220) (Issuer)

    9/3/25 9:50:04 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kotte Vijay bought $100,275 worth of shares (7,500 units at $13.37), increasing direct ownership by 1% to 653,630 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    11/15/23 10:10:34 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Leadership Updates

    Live Leadership Updates

    View All

    Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy

    CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t

    10/10/24 9:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Vance Johnston as Chief Financial Officer

    CHICAGO, Dec. 6, 2021 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today that Vance Johnston will join the Company as Chief Financial Officer (CFO) on December 7, 2021.  As previously announced, Travis Matthiesen, the Company's current CFO, will transition to the role of Chief Transformation Officer and will work closely with Johnston to ensure a smooth transition. "We are very pleased that Vance will be joining the GoHealth executive team as CFO," said Clint Jones, co-fou

    12/6/21 4:05:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Dr. Paul Hain, M.D. as Chief Medical Officer

    CHICAGO, Dec. 1, 2020 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer. In this newly created role, Dr. Hain will work side-by-side with GoHealth's growing TeleCare team, directly building clinical functions within the recently developed Encompass Platform, a digital health solution that provides strategic value to GoHealth members and enterprise partners. Dr. Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of he

    12/1/20 8:06:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Financials

    Live finance-specific insights

    View All

    GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results

    Disciplined posture reflects consumer-first enrollment, an intentional Medicare Advantage pullback driven by market realities, continued special needs plans ("SNP") leadership, targeted AI investment, and a focus on cash, back-book durability, and consolidation readiness CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and twelve months ended December 31, 2025. GoHealth's Chief Executive Officer, Vijay Kotte commented, "The Medicare Advantage market remains in a structural reset going into 2026, and our

    3/31/26 4:20:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Prioritizes Retention, Quality, and Strategic Flexibility as Medicare Advantage Market Rationalizes; Reports Third Quarter 2025 Results

    CHICAGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and nine months ended September 30, 2025. The Company navigated a materially different Medicare Advantage environment by intentionally reducing Medicare Advantage volume, conserving liquidity, and preserving the core capabilities required to scale when market conditions stabilize. Based on our analysis, health plans continue to emphasize margin integrity, renewal stability, and long-term member value over raw enrollment growth. GoHealth anticipated this shi

    11/13/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth to Announce Third Quarter 2025 Results on November 13, 2025

    CHICAGO, Nov. 11, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its third quarter 2025 financial results on the morning of November 13, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand lis

    11/11/25 9:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:15:20 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:03:57 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    5/19/23 6:08:49 AM ET
    $GOCO
    Specialty Insurers
    Finance